Budget Impact Model of Cobimetinib in Combination with Vemurafenib For Previously Untreated Braf V600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.146
https://www.valueinhealthjournal.com/article/S1098-3015(17)30480-1/fulltext
Title :
Budget Impact Model of Cobimetinib in Combination with Vemurafenib For Previously Untreated Braf V600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30480-1&doi=10.1016/j.jval.2017.08.146
First page :
A423
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
126